23 results
10-K
2022 FY
EX-14.1
SCNI
Scinai Immunotherapeutics Ltd
17 Apr 23
Annual report
4:06pm
business. This Code of Business Conduct and Ethics (this “Code”) applies to the Company’s employees, officers and directors (each an “Associate … to the highest standards of ethics and business conduct in dealing with each other and with the Company’s shareholders, customers, vendors, partners
10-K
2022 FY
SCNI
Scinai Immunotherapeutics Ltd
17 Apr 23
Annual report
4:06pm
, such entity or person must receive special authorization from the ethics committee (also known as a “Helsinki Committee”) and general manager … , special fertility trials and similar trials, an additional authorization of the overseeing institutional ethics committee. The institutional ethics
424B5
SCNI
Scinai Immunotherapeutics Ltd
28 Dec 21
Prospectus supplement for primary offering
5:20pm
regulatory authorities, an independent institutional review board or an independent ethics committee at each medical institution proposing to participate … result in regulatory sanctions and serious harm to our reputation. Our board of directors adopted a Code of Ethics. However, it is not always possible
424B5
SCNI
Scinai Immunotherapeutics Ltd
27 Dec 21
Prospectus supplement for primary offering
6:22am
or an independent ethics committee at each medical institution proposing to participate in the conduct of the clinical trial generally must review … board of directors adopted a Code of Ethics. However, it is not always possible to identify and deter employee misconduct, and the precautions we
424B5
10s493
1 Feb 21
Prospectus supplement for primary offering
5:08pm
424B5
cxnt6luazu78zb0h
29 Jan 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
fk62ykh
2 Oct 20
Condensed Interim Financial Statements
12:00am
424B5
0c9x xdu9yp
2 Oct 20
Prospectus supplement for primary offering
12:00am
POS AM
g72 dgfxj
7 Jan 20
Prospectus update (post-effective amendment)
10:51am
F-1/A
r7k93hkh
7 Jun 19
Registration statement (foreign) (amended)
11:42am
F-1/A
fbk5aixmts 37zarb62
6 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1/A
kye4bu1of6tts lgarks
30 May 19
Registration statement (foreign) (amended)
8:46am
F-1/A
4jt90wv
6 May 19
Registration statement (foreign) (amended)
10:03am
6-K
EX-99.1
iqooupyj
23 Apr 19
Notice of an Extraordinary General Meeting of Shareholders
6:18am
F-1
0ke1a0egzv4ds
25 Mar 19
Registration statement (foreign)
4:08pm